Passage Bio Company Contacts

We are a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these... Read More
Contacts

Country

United States

City

Philadelphia

Headquarters

Philadelphia, Pennsylvania

Profile

Founded

2017

Industry

Biotechnology Research

Size

51 - 200

Funding

Total Rounds

3

Last Round

Wed Jan 20 2021

Last Round Series

Post IPO equity

Last Round Raised

$ 154,000,000